Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Clinical trial NCT02531438 · COMPLETED

Trial details

NCT number: NCT02531438
Sponsor: Paratek Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Pneumonia Community-Acquired Infections

Start date: 2015-11-01
Primary completion: 2017-02-05
Enrollment: 774

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.